Fate Therapeutics

Alps parachute rainbow mountains
Biotech

J&J, Bayer, Santa Ana, Regenxbio and more—Chutes & Ladders

J&J exec to retire after 17 years. Bayer’s top biotech leader departs. Former Kite exec takes the reins of new biotech.
Layoffs

Fate resets as J&J deal ends, cutting pipeline and head count

Jan 6, 2023 6:50am
image of a few paragliders

Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders

Jun 3, 2022 9:30am
cancer cell surrounded by killer T cells

Bristol Myers Squibb-backed Clade nabs a meaty $87M series A

Nov 3, 2021 7:00am
Red blood cells

Fate Therapeutics' stock drops on blood cancer readout

Aug 20, 2021 8:20am
exit

Fate Therapeutics sees CSO and biotech veteran Shoemaker retire

Mar 25, 2021 7:45am